SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (183)2/27/2004 9:52:27 AM
From: mopgcw  Read Replies (1) of 411
 
7:10AM CV Therapeutics files $300 mln mixed shelf, announces offering of 1.6 mln shares at $15.54 (CVTX) 16.03: Co files with the SEC to offer up to $300 mln in various securities. In a separate filing, co discloses that it is offering 1.6 mln shares to Mainfield Enterprises at a price of $15.54/share. Total purchase price $25 mln.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News